Figure 5.
tDCS-induced microglial somatic enlargement depends on B2AR and A1AR pathways. A, Comparison between median microglial soma size between Sham- and tDCS-treated IP3R2 KO mice (Sham group: 6 mice; tDCS group: 7 mice; p = 0.73f). B, C, Comparison of microglial soma size between Sham- and tDCS-treated wild-type strain C57BL/6J with prazosin (B; Sham group: 7 mice; tDCS group: 7 mice; p = 0.8 × g), or ICI181551 pretreatment (C; Sham group: 6 mice; tDCS group: 6 mice; p = 0.48h). N.S. not significant.